首页> 美国卫生研究院文献>other >In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism
【2h】

In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism

机译:草酸钙水提液中草酸钙结晶动力学和晶体形态的体外影响:潜在抗结石机制的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ceterach officinarum Willd is a plant widespread throughout Europe and used in southern Italy as a diuretic. Beliefs in the benefits of C. officinarum aqueous extract in the treatment of calcium oxalate kidney stones are widely held. Little is known, however, about the actual mechanism of its antilithiatic action. Our results in this in vitro study corroborate C. officinarum aqueous extract as a good source of antioxidants with a high antioxidant effects. Our results also demonstrate a major impact of C. officinarum aqueous extract on in vitro induced calcium oxalate crystallization kinetics and crystal morphology, showing its critical role in kidney stone formation and/or elimination. We show that progressively increasing doses of C. officinarum aqueous extract cause a sequence of effects. A powerful inhibitory action on calcium oxalate monohydrate (COM) growth and aggregation is first observed. C. officinarum aqueous extract also appears highly effective in stimulating nucleation increasing the number and reducing the size of COM crystals, which become progressively thinner, rounded and concave in a dose-dependent manner. These shape-modified COM crystals are known to be less adherent to renal tubular cells and more easily excreted through the urinary tract preventing kidney stone formation. Further, C. officinarum aqueous extract promotes the formation of calcium oxalate dihydrate (COD) rather than the monohydrate so that, at the highest concentrations used, only COD crystals are observed, in significant greater numbers with a clear reduction in their size, in a dose-dependent manner. Furthermore, AFM analyses allowed us to reveal the presence of C. officinarum component(s) on the surfaces of COD and modified COM crystals. The crystal surface adsorbed component(s) are shown to be similarly active as the total aqueous extract, suggesting a trigger factor which may direct crystal modification towards COD forms. In urolithiasis pathogenesis COD crystals are less dangerous than the COM forms due to their lower affinity for renal tubular cells. Our results are important in understanding the mechanisms which guide the modification induced by C. officinarum on the crystallization process. Based on these data, together with no adverse toxic effect being observed on the in vitro model of human intestinal enterocytes, C. officinarum aqueous extract could represent an attractive natural therapy for the treatment of urolithiasis.
机译:Ceterach officinarum Willd是一种遍及欧洲的植物,在意大利南部用作利尿剂。人们普遍相信C. officinarum水性提取物可治疗草酸钙肾结石。然而,对其抗石棉作用的实际机理知之甚少。在这项体外研究中,我们的结果证实了厚皮衣藻提取物是具有高抗氧化作用的抗氧化剂的良好来源。我们的结果还证明了山茱off水提取物对体外诱导的草酸钙结晶动力学和晶体形态的重大影响,显示了其在肾结石形成和/或消除中的关键作用。我们表明,逐渐增加剂量的C. officinarum水溶液提取物会引起一系列效应。首先观察到对草酸钙一水合物(COM)生长和聚集的强大抑制作用。 C. officinarum水提取物在刺激成核,增加数量和减小COM晶体方面似乎也非常有效,COM晶体以剂量依赖性方式逐渐变薄,变圆和凹入。已知这些形状修饰的COM晶体与肾小管细胞的粘附较少,更容易通过尿道排泄,从而防止肾结石形成。此外,C。officinarum水提取物可促进草酸钙二水合物(COD)的形成,而不是一水合物的形成,因此,在所用的最高浓度下,仅观察到COD晶体的数量显着增加,且其尺寸明显减小,这明显增多。剂量依赖性。此外,原子力显微镜分析使我们能够揭示在化学需氧量和改性COM晶体表面上存在C. inas 组分。晶体表面吸附的组分显示出与总水性提取物相似的活性,表明触发因素可能将晶体修饰引导至COD形式。在尿路结石的发病机理中,由于COD晶体对肾小管细胞的亲和力较低,因此其危险性不如COM晶体。我们的结果对于理解指导 C 引起的修饰的机制非常重要。 officinarum 关于结晶过程。基于这些数据,在人肠小肠细胞 C 体外模型中未观察到不良毒性作用。山茱aqueous水提物可能是治疗尿路结石的一种有吸引力的自然疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号